JUNS GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Jupiter Neurosciences Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability. Nugevia brings clinical-grade science to the supplement space, supporting mental clarity, skin health, and mitochondrial function. The Company's prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson's disease, including indications such as Alzheimer's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS.
Current Price
$0.24
+16.93%Profile
Valuation (TTM)
Market Cap$7.06M
P/E-0.77
EV—
P/B—
Shares Out29.44M
P/Sales174.48
Revenue$40448.00
EV/EBITDA—
Jupiter Neurosciences Inc (JUNS) Quality Analysis
JUNS Profitability
Profitability trend analysis coming soon
JUNS Growth
Growth trend analysis coming soon
JUNS Financial Health
Financial health indicators coming soon
JUNS Quality & Fundamental Analysis
Jupiter Neurosciences Inc (JUNS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Jupiter Neurosciences Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Jupiter Neurosciences Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -22690.83%. Return on assets (ROA) stands at -164.95%.
with a current ratio of 0.65. Operating margin is -40873.19%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Jupiter Neurosciences Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.